Arabic Arabic English English French French German German
dark

ADC Therapeutics Enters Into a Financing Agreement with HealthCare Royalty for Up to $325 Million

ADC Therapeutics SA today announced it had entered into a royalty purchase agreement with HealthCare Royalty Partners (HealthCare Royalty). Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

PharmaBlock Announces the Appointment of Dr. Xudong Wei as Senior Vice President to Lead and Enhance Small Molecule CDMO Services

Next Post

Interim report April – June 2021

Related Posts
Total
0
Share